Our mission at Elypta is to prevent cancer mortality through earlier detection and closer monitoring. We are developing a liquid biopsy platform based on a scalable laboratory assay and artificial intelligence algorithms trained by our clinical database. Our approach is to measure a system of metabolic biomarkers (a profile of metabolites found to reflect an important process in cancer) in both blood and urine. Our learning algorithms then pin down the patterns specific to various forms of cancer using clinical data.
We are based in Stockholm (Sweden)
and we are always looking to meet exceptional people interested in working with us
To learn more and to apply, go to: